CRVS

Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in Burlingame, California, dedicated to pioneering immuno-oncology therapies aimed at treating various cancers. With a strong pipeline of proprietary drug candidates, the company focuses on enhancing immune responses and improving patient outcomes through precision medicine strategies. By cultivating strategic partnerships and employing innovative research methodologies, Corvus is positioning itself as a significant contributor to the advancement of cancer therapeutics, thereby establishing a compelling presence in the dynamic oncology sector.